Login
$ECOR
$7.44 +$0.39 (5.53%) Close

$ECOR 3 SEC Filings

Filed On Filing
14 Apr 2026 Form 3: Fox Michael, Chief Operating Officer

No securities owned

12 Sep 2025 Form 3: Bonfiglioli Elena, Director

No securities owned

05 Aug 2025 Form 3: Theofilos James Charles, Director

Holds 1,391 shares of Common Stock

04 Oct 2024 Form 3: Lev Joshua S., Chief Financial Officer

Holds 16,333 shares of Common Stock

18 Dec 2023 Form 3: Theofilos Charles Steve, Director

Holds 412,410 shares of Common Stock

16 Mar 2022 Form 3: Goldstein Julie Ann, Director

Holds 360,212 shares of Common Stock

16 Mar 2022 Form 3: Wilber Patricia, Director

No securities owned

06 Apr 2020 Form 3: Cuneo F Peter, Director

No securities owned

06 Apr 2020 Form 3: Patton Thomas M, Director

No securities owned

06 Apr 2020 Form 3: Gandolfo John P, Director

No securities owned

03 Oct 2019 Form 3: Goldberger Daniel S, Director

Holds 0 shares of No securities are beneficially owned.

03 Apr 2019 Form 3: Posner Brian M, Chief Financial Officer
22 Jun 2018 Form 3: Merck Global Health Innovation Fund, Llc, 10% owner

Holds 3,179,366 shares of Common Stock

21 Jun 2018 Form 3: Vraniak Glenn S., Chief Financial Officer

Holds 117,835 shares of Common Stock

21 Jun 2018 Form 3: Tullis James L L, Director

Holds 111,227 shares of Common Stock

21 Jun 2018 Form 3: Staats Peter S., Chief Medical Officer

Holds 144,636 shares of Common Stock

21 Jun 2018 Form 3: Ondra Stephen, Director
21 Jun 2018 Form 3: Moody Trevor J, Director

Holds 37,166 shares of Common Stock

21 Jun 2018 Form 3: Errico Thomas J., Director

Holds 456,651 shares of Common Stock

21 Jun 2018 Form 3: Errico Joseph P, Director

Holds 632,349 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support